These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 14985428)

  • 21. Altered p53 and NOX1 activity cause bioenergetic defects in a SCA7 polyglutamine disease model.
    Ajayi A; Yu X; Wahlo-Svedin C; Tsirigotaki G; Karlström V; Ström AL
    Biochim Biophys Acta; 2015; 1847(4-5):418-428. PubMed ID: 25647692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy: polyQ toxic fragment turnover.
    Duncan C; Papanikolaou T; Ellerby LM
    Autophagy; 2010 Feb; 6(2):312-4. PubMed ID: 20104018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice.
    Alves S; Cormier-Dequaire F; Marinello M; Marais T; Muriel MP; Beaumatin F; Charbonnier-Beaupel F; Tahiri K; Seilhean D; El Hachimi K; Ruberg M; Stevanin G; Barkats M; den Dunnen W; Priault M; Brice A; Durr A; Corvol JC; Sittler A
    Acta Neuropathol; 2014 Nov; 128(5):705-22. PubMed ID: 24859968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice.
    Garden GA; Libby RT; Fu YH; Kinoshita Y; Huang J; Possin DE; Smith AC; Martinez RA; Fine GC; Grote SK; Ware CB; Einum DD; Morrison RS; Ptacek LJ; Sopher BL; La Spada AR
    J Neurosci; 2002 Jun; 22(12):4897-905. PubMed ID: 12077187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype.
    Aleman TS; Cideciyan AV; Volpe NJ; Stevanin G; Brice A; Jacobson SG
    Exp Eye Res; 2002 Jun; 74(6):737-45. PubMed ID: 12126946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes.
    Latouche M; Lasbleiz C; Martin E; Monnier V; Debeir T; Mouatt-Prigent A; Muriel MP; Morel L; Ruberg M; Brice A; Stevanin G; Tricoire H
    J Neurosci; 2007 Mar; 27(10):2483-92. PubMed ID: 17344386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy.
    Merienne K; Friedman J; Akimoto M; Abou-Sleymane G; Weber C; Swaroop A; Trottier Y
    Neurobiol Dis; 2007 Mar; 25(3):571-81. PubMed ID: 17189700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse.
    Wang HL; Hu SH; Chou AH; Wang SS; Weng YH; Yeh TH
    Neuropharmacology; 2013 Jul; 70():1-11. PubMed ID: 23347954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinocerebellar ataxia 7 (SCA7).
    Lebre AS; Brice A
    Cytogenet Genome Res; 2003; 100(1-4):154-63. PubMed ID: 14526176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models.
    Marinello M; Werner A; Giannone M; Tahiri K; Alves S; Tesson C; den Dunnen W; Seeler JS; Brice A; Sittler A
    Dis Model Mech; 2019 Jan; 12(1):. PubMed ID: 30559154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytes.
    McCullough SD; Xu X; Dent SY; Bekiranov S; Roeder RG; Grant PA
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21319-24. PubMed ID: 23236151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice.
    Clark HB; Orr HT
    J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyglutamine-expanded ataxin-7 causes cerebellar dysfunction by inducing transcriptional dysregulation.
    Chou AH; Chen CY; Chen SY; Chen WJ; Chen YL; Weng YS; Wang HL
    Neurochem Int; 2010 Jan; 56(2):329-39. PubMed ID: 19909779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyglutamine toxicity induces rod photoreceptor division, morphological transformation or death in spinocerebellar ataxia 7 mouse retina.
    Yefimova MG; Messaddeq N; Karam A; Jacquard C; Weber C; Jonet L; Wolfrum U; Jeanny JC; Trottier Y
    Neurobiol Dis; 2010 Oct; 40(1):311-24. PubMed ID: 20600911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice.
    Chort A; Alves S; Marinello M; Dufresnois B; Dornbierer JG; Tesson C; Latouche M; Baker DP; Barkats M; El Hachimi KH; Ruberg M; Janer A; Stevanin G; Brice A; Sittler A
    Brain; 2013 Jun; 136(Pt 6):1732-45. PubMed ID: 23518714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7.
    Ramachandran PS; Boudreau RL; Schaefer KA; La Spada AR; Davidson BL
    Mol Ther; 2014 Sep; 22(9):1635-42. PubMed ID: 24930601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell Death Mechanisms in a Mouse Model of Retinal Degeneration in Spinocerebellar Ataxia 7.
    Lebon C; Behar-Cohen F; Torriglia A
    Neuroscience; 2019 Feb; 400():72-84. PubMed ID: 30625334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment.
    Mookerjee S; Papanikolaou T; Guyenet SJ; Sampath V; Lin A; Vitelli C; DeGiacomo F; Sopher BL; Chen SF; La Spada AR; Ellerby LM
    J Neurosci; 2009 Dec; 29(48):15134-44. PubMed ID: 19955365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct inhibition of Gcn5 protein catalytic activity by polyglutamine-expanded ataxin-7.
    Burke TL; Miller JL; Grant PA
    J Biol Chem; 2013 Nov; 288(47):34266-34275. PubMed ID: 24129567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.